240 related articles for article (PubMed ID: 24158229)
1. Statins in chronic kidney disease: what do meta-analyses tell us?
Upadhyay A
Clin Exp Nephrol; 2014 Apr; 18(2):278-81. PubMed ID: 24158229
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based statin prescription for cardiovascular protection in renal impairment.
Fabbian F; De Giorgi A; Pala M; Tiseo R; Manfredini R; Portaluppi F
Clin Exp Nephrol; 2011 Aug; 15(4):456-63. PubMed ID: 21556807
[TBL] [Abstract][Full Text] [Related]
3. Statins in chronic kidney disease: cardiovascular risk and kidney function.
Deedwania PC
Postgrad Med; 2014 Jan; 126(1):29-36. PubMed ID: 24393749
[TBL] [Abstract][Full Text] [Related]
4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
5. Is lipid management effective for all stages of CKD?
Ku E; Campese V
Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
[TBL] [Abstract][Full Text] [Related]
6. Statins in the management of dyslipidemia associated with chronic kidney disease.
Epstein M; Vaziri ND
Nat Rev Nephrol; 2012 Feb; 8(4):214-23. PubMed ID: 22349484
[TBL] [Abstract][Full Text] [Related]
7. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
[TBL] [Abstract][Full Text] [Related]
8. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis.
Su X; Zhang L; Lv J; Wang J; Hou W; Xie X; Zhang H
Am J Kidney Dis; 2016 Jun; 67(6):881-92. PubMed ID: 26905361
[TBL] [Abstract][Full Text] [Related]
9. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.
Rysz J; Gluba-Brzózka A; Banach M; Więcek A
Int Urol Nephrol; 2015 May; 47(5):805-13. PubMed ID: 25758011
[TBL] [Abstract][Full Text] [Related]
10. Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Lin YC; Lai TS; Wu HY; Chou YH; Chiang WC; Lin SL; Chen YM; Chu TS; Tu YK
Clin Pharmacol Ther; 2020 Oct; 108(4):833-843. PubMed ID: 32320058
[TBL] [Abstract][Full Text] [Related]
11. Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.
Zhang X; Xiang C; Zhou YH; Jiang A; Qin YY; He J
BMC Cardiovasc Disord; 2014 Feb; 14():19. PubMed ID: 24529196
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy.
Athyros VG; Tziomalos K; Karagiannis A
Expert Rev Cardiovasc Ther; 2015; 13(9):1059-66. PubMed ID: 26206619
[TBL] [Abstract][Full Text] [Related]
13. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
[TBL] [Abstract][Full Text] [Related]
14. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.
Palmer SC; Craig JC; Navaneethan SD; Tonelli M; Pellegrini F; Strippoli GF
Ann Intern Med; 2012 Aug; 157(4):263-75. PubMed ID: 22910937
[TBL] [Abstract][Full Text] [Related]
15. Dyslipidemia in patients with chronic kidney disease.
Hager MR; Narla AD; Tannock LR
Rev Endocr Metab Disord; 2017 Mar; 18(1):29-40. PubMed ID: 28000009
[TBL] [Abstract][Full Text] [Related]
16. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
Hou W; Lv J; Perkovic V; Yang L; Zhao N; Jardine MJ; Cass A; Zhang H; Wang H
Eur Heart J; 2013 Jun; 34(24):1807-17. PubMed ID: 23470492
[TBL] [Abstract][Full Text] [Related]
17. Dyslipidemia in Patients with Kidney Disease.
Thobani A; Jacobson TA
Cardiol Clin; 2021 Aug; 39(3):353-363. PubMed ID: 34247749
[TBL] [Abstract][Full Text] [Related]
18. Effects of statin therapy on cerebrovascular and renal outcomes in patients with predialysis advanced chronic kidney disease and dyslipidemia.
Chung CM; Lin MS; Hsu JT; Hsiao JF; Chang ST; Pan KL; Lin CL; Lin YS
J Clin Lipidol; 2017; 11(2):422-431.e2. PubMed ID: 28502499
[TBL] [Abstract][Full Text] [Related]
19. LDL-cholesterol lowering and renal outcomes.
Waters DD
Curr Opin Lipidol; 2015 Jun; 26(3):195-9. PubMed ID: 25887677
[TBL] [Abstract][Full Text] [Related]
20. Statins in chronic kidney disease and kidney transplantation.
Kassimatis TI; Goldsmith DJ
Pharmacol Res; 2014 Oct; 88():62-73. PubMed ID: 24995940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
